Evidence for Essential Requirements Under UK Rules

1. Key takeaways

The UK’s substantive requirements for devices are the relevant essential requirements, and conformity with them is assessed through the route set out in reg 9. The method GRZAN recommends for building the evidence is a verifiable mapping matrix that runs each essential requirement as a row against the supporting evidence as columns. Typical evidence categories include test reports, risk analysis documentation (within an ISO 14971 system), clinical evaluation, biological evaluation, sterilisation validation and software lifecycle documentation. The matrix is more than a formatting exercise. It is the instrument that answers two questions quickly and credibly: which requirement does this evidence support, and where does the evidence live. When the MHRA examines registration data or requests documentation, the manufacturer’s ability to navigate from requirement to evidence in minutes, rather than days, is what converts a technically adequate file into a demonstrably compliant one. The sections below cover the legal routes for demonstrating conformity, the role of designated standards, the retrieval deadline that shapes how evidence must be organised, and the layered structure GRZAN recommends for keeping it all navigable. The structure matters because the UK regime asks two questions of every file: how conformity was demonstrated, and how quickly that demonstration can be produced when it is requested.

2. Legal basis

• UK MDR 2002 (SI 2002/618, as amended): reg 8 (the relevant essential requirements), reg 9 (the assessment of conformity with the relevant essential requirements), reg 12 (exemptions from reg 8 and reg 10), reg 3A (designated standards) and Schedule 2A.
• SI 2024/1368 (in force 16 June 2025): reg 3 amends the definition of relevant essential requirements in reg 2(1); Part 4A requires PMS data to be fed back into the technical documentation.

3. Expert insights

Insight one: reg 9 provides an assessment route, not a checklist. Conformity can be demonstrated through designated standards (reg 3A), through existing technical documentation, or through other demonstrable means. That flexibility is welcome, but it carries a consequence: the burden of proof rests with the manufacturer. Because there is no single mandated method, the manufacturer must be able to show, for every requirement, why the chosen route supports the conclusion of conformity. When the MHRA asks, the answer must already exist in the file; it cannot be improvised during the response window. This is why GRZAN treats the mapping matrix not as documentation decoration but as the core evidential instrument of the UK technical file. Recording, in the matrix itself, which route supports each requirement keeps the file’s logic visible without interviews.

Insight two: designated standards are a tool for presumption of conformity. Reg 3A defines the legal effect of designated standards. Applying them can simplify the demonstration of conformity, but they are not the only route, and their use does not equal automatic compliance. A manufacturer relying on a designated standard still owns the overall conformity conclusion, must confirm the standard’s version and designated status, and must be ready to show how the standard’s application maps onto the specific device. Treat the standard as one strong column in the matrix, not as a substitute for the matrix itself. Where a designated standard is not applied, or only partially applied, the rationale should be documented, because departures from presumption routes attract the most questions.

Insight three: the evidence chain must withstand a 3 working day retrieval. Part 4A, reg 44ZR, requires that when the MHRA requests PMS reports or PSURs, they are provided within 3 working days. The same responsiveness principle applies to the essential requirements evidence: if the supporting documents sit scattered across different systems, suppliers and geographies, the response window will close before the file is assembled. GRZAN recommends auditing the evidence chain annually against a simple test, namely whether any single requirement’s complete evidence can be retrieved and delivered within the deadline by the people who would actually be asked to do it. Suppliers holding test reports should be contracted for defined delivery timelines, since retrieval speed depends on parties outside the manufacturer’s own systems.

4. Practical recommendations

GRZAN recommends a three-layer evidence structure. The first layer is the essential requirements mapping matrix, kept to a one-page overview wherever possible. The second layer is, for each requirement, an evidence summary recording the report number, version, date and conclusion. The third layer is the underlying source documents themselves. The layers are cross-linked by reference numbers, so that any requirement can be traced from the matrix row, through the summary, to the original report in a few minutes. This structure serves two audiences at once. Internally, it makes annual updates cheap, because each layer changes at its own pace: the matrix rarely moves, the summaries move with each new report, and the source documents accumulate. Externally, it presents exactly the navigational path a reviewer needs, which is the difference between a file that supports the conformity claim and one that merely contains it. GRZAN suggests naming an owner for each layer and rehearsing the retrieval test annually, using an actual requirement chosen at random from the matrix.

5. Verification checklist

• □ A clause-by-clause essential requirements mapping matrix exists
• □ Every requirement carries an evidence reference, version and date
• □ The applicability of designated standards has been assessed (reg 3A)
• □ The exemption situations in reg 12 have been examined
• □ The three evidence layers can be retrieved within 3 working days

Regulatory information verified as of 29 October 2026.

GRZAN supports manufacturers entering the UK market with the preparation and maintenance of registration documentation and conformity documentation. Our services for the UK market include:

• UK Responsible Person (UKRP) appointment and authorisation letter support
• Full MHRA registration (DORS) filing and account lifecycle management
• Device classification, GMDN code selection and annual registration fee calculation
• Great Britain and Northern Ireland dual-pathway design and UK(NI) solutions
• Post-market surveillance (PMS) system setup, PMSR/PSUR preparation and vigilance reporting
• Serious incident and field safety corrective action (FSCA) emergency response
• UK regulatory change monitoring and compliance gap assessment

For tailored support with essential requirements evidence and conformity documentation for the UK market, contact GRZAN at info@grzanglobal.com.